在患有严重抑郁症的患者中,受COVID-19影响的多式联络成像特征显著
Taipeng Sun1, Chenguang Jiang2, Yubo Zhang2
1Department of Psychosomatics and Psychiatry, ZhongDa Hospital, School of Medicine, Southeast University, Nanjing, 210009, Jiangsu, China; Department of Medical Psychology, Huai'an No.3 People's Hospital, Huaian, 223001, Jiangsu, China.
Journal of psychiatric research
|February 5, 2025
概括
在健康个体中,COVID-19感染会损害白质 (WM),并且在严重抑郁症 (MDD) 患者中会恶化现有的WM损伤. 在这两组中,白质似乎比灰质更容易受到COVID-19的感染.
科学领域:
- 神经科学是一个神经科学.
- 传染性疾病 传染性疾病
- 精神病学是一个精神病学.
背景情况:
- 众所周知,COVID-19会导致大脑的结构和功能变化.
- 关于COVID-19对患有严重抑郁症 (MDD) 个体的具体影响的数据有限.
研究的目的:
- 研究COVID-19感染对MDD患者的大脑结构和功能的影响,与健康对照 (HCs) 相比.
- 在MDD患者和HC患者中识别受COVID-19影响的特定大脑区域和白质道.
主要方法:
- 利用MRI扫描,包括T1加权成像,扩散张力成像 (DTI) 和静止状态功能性MRI.
- 将四组进行比较:MDD患者在COVID-19之前 (n=165) 和之后 (n=70),HC患者在COVID-19之前 (n=108) 和之后 (n=57).
- 在2022年1月至2023年8月期间收集的数据.
主要成果:
- COVID-19主要导致白质 (WM) 与灰质 (GM) 的结构变化.
- 在MDD患者中受到影响的特定WM通道包括上方纵向囊,小,以及环-环回.
- 在GM和WM中观察到功能性变化,特别是在补充运动区域,左角环,杏仁体,副海马环和各种WM区域.
结论:
- 在健康个体中,COVID-19感染会导致显著的微观结构性WM损伤.
- 在MDD患者中,COVID-19加剧了先前存在的白质微观结构损伤.
- 在MDD患者和健康对照中,白质似乎比灰质更容易受到COVID-19相关的损伤.
更多相关视频
10:43Developing Neuroimaging Phenotypes of the Default Mode Network in PTSD: Integrating the Resting State, Working Memory, and Structural Connectivity
Published on: July 1, 2014
15.0K
07:12Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method
Published on: August 2, 2021
3.4K
相关概念视频
Depression: Overview
210
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
210
Antidepressant Drugs: MAOIs and Other Agents
183
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
183
